The great upsurge in genetic engineering techniques at that time offered a glimpse of many possibilities for money-earning uses of natural substances by living-resource-based industries. In this context, the Convention on Biological Diversity, a measure adopted in Rio de Janeiro in 1992, advocated the development of trade agreements between holders and users of genetic resources, foreseeing a fair and equitable sharing of benefits derived from such resources.
Fifteen years after the signature of the Convention on Biological Diversity, a multidisciplinary team involving researchers from the IRD and other institutions conducted a review of the current situation. They highlighted the gap between the theories circulating around the Convention adopted in Brazil and the real situations prevailing in transactions, expectations and constraints which characterize the relations being established between the different parties involved: local communities, States of the South, industrial companies.
Over recent years, strong media coverage of “pillage” of local resources, food plants or products of traditional pharmacopoeias, on which patents had been taken out, appeared as signs of an active biopiracy. Some States of the South, supported by the non governmental organizations (NGOs), have therefore seen looming the risk of watching powerless an unbridled exploitation of indigenous people’s knowledge and resources, with insufficient means to stem the flow. Others considered that if regulated and reasoned, the use of genetic resources could favour their conservation while being a source of revenue for local communities and the countries of the South, but also allow biotechnological innovations and generate transfer of technology.
The idea of a market, bringing face to face a supply of genetic resources by the South and a demand emanating from the North, attracted by promises of financial reward, held up the bright prospect of development of these transactions. The representations conveyed by the Convention on Biological Diversity turn out to be simplistic. Analysis of the demand in the agricultural sector and the pharmaceutical industry in terms of research and development put into perspective the needs of these different users of biodiversity and provided an updated description of them. The issues at stake for the pharmaceutical firms concern rather more the control over property rights protecting the synthesis of new compounds than access to genetic resources. Moreover, pharmaceutical industry demand bears at least as much on microorganisms from soils or the deep sea floors, even on chemical products and substances stemming from nanobiotechnology, as on “unknown plants” of tropical forests. Similarly, the recourse to indigenous knowledge for producing innovations and, even more so, the possibility for the peoples who have them to benefit from them seem to have been greatly overestimated. On the supply side, it turned out that people handle their human relations in accordance with their environment and not the genetic resources assimilated with such merchandise. In addition, they do not always have the capacities for negotiating on an equal footing with industry. Fair trading, labels or geographical indications can be used to promote products generating from particular indigenous savoir-faire, but these instruments do not directly concern biodiversity. As for patents coming from the industrial world, they are not adapted for protecting collective knowledge and heritage.
The gulf that separates the founding representations of the Convention on Biological Diversity from the real situations is particularly evident with the problem of biopiracy. Extensive media coverage of certain cases like ayahuasca, a beverage based on plants with hallucinogenic properties consumed traditionally by shamans of Amazonian Indian tribes, or maca, a plant from the pharmacopoeia of Peru reputed for its aphrodisiac virtues, gives the illusion that biodiversity relates to elements whose interpretation remains indisputable. The term in fact encompasses many different notions: filing of patents on applications or properties of plants collected in local communities?with or without consent?, disclosure or use of traditional knowledge for commercial ends, filing of common names as trade names, agreements whose clauses or implementation are unsatisfactory and so on. This gives it a rather hazy status which makes it more difficult to establish public policies that might ensure the conservation of biodiversity.
Grégory Fléchet | alfa
Forest Management Yields Higher Productivity through Biodiversity
14.10.2016 | Technische Universität München
Farming with forests
23.09.2016 | University of Illinois College of Agricultural, Consumer and Environmental Sciences (ACES)
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences